ArticleHepatology international2016

Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.

Yuanyuan Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.